| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.049 | 0.3 |